Review of Innovation Law and Policy: Preserving the Future of Personalized Medicine: by Rachel Sachs
From the review:
I highly recommend two recently posted articles on declining innovation incentives for diagnostic tests, particularly due to changes in patentable subject matter doctrine. In Innovation Law and Policy: Preserving the Future of Personalized Medicine, Rachel Sachs (Petrie-Flom Fellow at Harvard Law) examines the intersection of IP with FDA regulation and health law, joining a growing body of scholarship that seeks to contextualize IP in a broader economic context.
Read the Full Article
Tags
fda health law policy innovation intellectual property rachel sachs regulation